Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Not Confirmed
Not Confirmed
05-06 June, 2025
Not Confirmed
Not Confirmed
05-06 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Industry Trade Show
Not Confirmed
05-06 June, 2025
Industry Trade Show
Not Confirmed
05-06 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
14 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/14/3060798/0/en/SynOx-Therapeutics-Receives-Fast-Track-Designation-from-U-S-Food-and-Drug-Administration-for-Emactuzumab-for-Tenosynovial-Giant-Cell-Tumours-TGCT.html
01 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/01/3053137/0/en/SynOx-Therapeutics-Announces-Board-Chair-Transition-to-Align-with-Advancing-Regulatory-and-Commercialization-Strategy.html
07 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/07/2976482/0/en/SynOx-Therapeutics-Further-Strengthens-Executive-Team-with-Appointments-of-U-S-Based-Chief-Medical-Officer-and-Chief-Commercial-Officer.html
30 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/30/2971571/0/en/SynOx-Therapeutics-Adds-New-Investor-and-Capital-to-Series-B-Financing-Raising-Total-to-92-Million-and-Doses-First-Patients-in-Phase-3-Trial.html
30 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/synox-therapeutics-secures-up-to-35m-debt-financing-with-hercules-capital-to-progress-development-and-commercialisation-of-emactuzumab-302130420.html
30 Apr 2024
// PHARMACEUTICAL MANUFACTURING
https://pharmaceuticalmanufacturer.media/pharma-manufacturing-news/pharma-finance-and-investment-news/synox-therapeutics-secures-up-to-35m-debt-financing/
ABOUT THIS PAGE